Prelude Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,372
| Closed | -$404K | – | 1176 |
|
|
2022
Q3 | $404K | Sell |
7,372
-13,857
| -65% | -$759K | 0.01% | 720 |
|
|
2022
Q2 | $1.4M | Buy |
+21,229
| New | +$1.4M | 0.04% | 323 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1379 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1359 |
|
|
2020
Q3 | – | Sell |
-18,860
| Closed | -$998K | – | 1375 |
|
|
2020
Q2 | $998K | Buy |
+18,860
| New | +$998K | 0.06% | 164 |
|
|
2020
Q1 | – | Sell |
-1,067
| Closed | -$53K | – | 968 |
|
|
2019
Q4 | $53K | Sell |
1,067
-12,038
| -92% | -$598K | ﹤0.01% | 922 |
|
|
2019
Q3 | $584K | Buy |
13,105
+11,665
| +810% | +$520K | 0.03% | 254 |
|
|
2019
Q2 | $59K | Sell |
1,440
-22,303
| -94% | -$914K | ﹤0.01% | 750 |
|
|
2019
Q1 | $960K | Sell |
23,743
-7,733
| -25% | -$313K | 0.05% | 172 |
|
|
2018
Q4 | $1.2M | Sell |
31,476
-261
| -0.8% | -$9.91K | 0.08% | 168 |
|
|
2018
Q3 | $1.26M | Buy |
31,737
+10,886
| +52% | +$431K | 0.07% | 195 |
|
|
2018
Q2 | $732K | Buy |
20,851
+192
| +0.9% | +$6.74K | 0.05% | 307 |
|
|
2018
Q1 | $722K | Buy |
20,659
+18,476
| +846% | +$646K | 0.05% | 307 |
|
|
2017
Q4 | $76K | Buy |
2,183
+473
| +28% | +$16.5K | 0.01% | 757 |
|
|
2017
Q3 | $58K | Buy |
1,710
+870
| +104% | +$29.5K | 0.01% | 953 |
|
|
2017
Q2 | $29K | Sell |
840
-11,026
| -93% | -$381K | ﹤0.01% | 1062 |
|
|
2017
Q1 | $370K | Buy |
+11,866
| New | +$370K | 0.04% | 340 |
|
|
2015
Q2 | – | Sell |
-1,200
| Closed | -$41K | – | 1589 |
|
|
2015
Q1 | $41K | Sell |
1,200
-8,400
| -88% | -$287K | 0.01% | 1344 |
|
|
2014
Q4 | $338K | Hold |
9,600
| – | – | 0.05% | 419 |
|
|
2014
Q3 | $343K | Hold |
9,600
| – | – | 0.05% | 468 |
|
|
2014
Q2 | $357K | Buy |
+9,600
| New | +$357K | 0.05% | 442 |
|